Healthcare provider profile · identity verified

Alvaro Ramirez, MD

Allopathic & Osteopathic Physicians|Family Medicine · JACKSON HEIGHTS, NY · NPI 1093703696

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Alvaro Ramirez, MD received $398.93 in general payments during 2025 across 6 reported records.

Gilead Sciences, Inc. accounted for 44.1% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 72 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 46 claims for Synthroid by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$398.93

6 reported records · 4 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Gilead Sciences, Inc.	Unresolved — no canonical attribution shown	$175.94	44.1%	2	2025
Axsome Therapeutics, Inc.	Unresolved — no canonical attribution shown	$109.46	27.4%	2	2025
ABBVIE INC.	Unresolved — no canonical attribution shown	$93.41	23.4%	1	2025
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$20.12	5.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$398.93	6

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Livdelzi Normalized: livdelzi	Drug	Gilead Sciences, Inc.	$150.00	1	2025
Source payment records 2025-03-26 · Gilead Sciences, Inc. · $150.00 · Open Payments source
Symbravo Normalized: symbravo	Drug	Axsome Therapeutics, Inc.	$109.46	2	2025
Source payment records 2025-08-01 · Axsome Therapeutics, Inc. · $23.37 · Open Payments source 2025-09-10 · Axsome Therapeutics, Inc. · $86.09 · Open Payments source
QULIPTA Normalized: qulipta	Drug	ABBVIE INC.	$93.41	1	2025
Source payment records 2025-08-21 · ABBVIE INC. · $93.41 · Open Payments source
Cologuard Collection Kit Normalized: cologuard collection kit	Device	Exact Sciences Corporation	$20.12	1	2025
Source payment records 2025-10-08 · Exact Sciences Corporation · $20.12 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	72	21
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	46	18

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	894	299
Losartan Potassium	Losartan Potassium	822	255
Amlodipine Besylate	Amlodipine Besylate	708	220
Alendronate Sodium	Alendronate Sodium	597	211
Levothyroxine Sodium	Levothyroxine Sodium	571	173
Metformin Hcl	Metformin Hcl	570	168
Diclofenac Sodium	Diclofenac Sodium	436	189
Vitamin D2	Ergocalciferol (Vitamin D2)	408	187
Omeprazole	Omeprazole	373	130
Simvastatin	Simvastatin	333	108
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	331	105
Meloxicam	Meloxicam	325	128
Montelukast Sodium	Montelukast Sodium	285	70
Metoprolol Succinate	Metoprolol Succinate	268	90
Albuterol Sulfate Hfa	Albuterol Sulfate	263	72
Farxiga	Dapagliflozin Propanediol	250	57
Rosuvastatin Calcium	Rosuvastatin Calcium	250	74
Pantoprazole Sodium	Pantoprazole Sodium	205	78
Meclizine Hcl	Meclizine Hcl	199	69
Lisinopril	Lisinopril	196	66
Fluticasone Propionate	Fluticasone Propionate	191	74
Triamcinolone Acetonide	Triamcinolone Acetonide	188	76
Tamsulosin Hcl	Tamsulosin Hcl	179	70
Gabapentin	Gabapentin	165	64
Azithromycin	Azithromycin	161	134
Hydrochlorothiazide	Hydrochlorothiazide	160	56
Alcohol Prep Pads	Alcohol Antiseptic Pads	113	56
Ibuprofen	Ibuprofen	112	47
Jardiance	Empagliflozin	109	30
Ibandronate Sodium	Ibandronate Sodium	104	36
Trazodone Hcl	Trazodone Hcl	102	35
Carvedilol	Carvedilol	100	32
Vascepa	Icosapent Ethyl	99	31
Clopidogrel	Clopidogrel Bisulfate	94	29
Ozempic	Semaglutide	86	21
Single Use Swab	Alcohol Antiseptic Pads	85	44
Naproxen	Naproxen	81	31
Famotidine	Famotidine	73	27
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	72	16
Linzess	Linaclotide	72	21
Metoprolol Tartrate	Metoprolol Tartrate	70	22
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	70	13
Eliquis	Apixaban	69	17
Zolpidem Tartrate	Zolpidem Tartrate	68	19
Ammonium Lactate	Ammonium Lactate	67	29
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	62	32
Olmesartan Medoxomil	Olmesartan Medoxomil	62	16
Mupirocin	Mupirocin	61	39
Janumet	Sitagliptin Phos/Metformin Hcl	58	15
Finasteride	Finasteride	56	21
Valacyclovir	Valacyclovir Hcl	56	21
Valsartan	Valsartan	56	21
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	54	31
Hydrocortisone	Hydrocortisone	54	22
Glipizide Er	Glipizide	52	14
Prednisone	Prednisone	52	41
Enalapril Maleate	Enalapril Maleate	51	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	36
Fenofibrate	Fenofibrate	50	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	18
Tradjenta	Linagliptin	48	suppressed
Januvia	Sitagliptin Phosphate	47	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	47	41
Ketoconazole	Ketoconazole	46	14
Synthroid	Levothyroxine Sodium	46	18
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	45	13
Betamethasone Dipropionate	Betamethasone Dipropionate	45	22
Dicyclomine Hcl	Dicyclomine Hcl	45	23
Atenolol	Atenolol	44	12
Propranolol Hcl	Propranolol Hcl	44	17
Sertraline Hcl	Sertraline Hcl	44	17
Diclofenac Potassium	Diclofenac Potassium	42	24
Spironolactone	Spironolactone	42	15
Pravastatin Sodium	Pravastatin Sodium	41	12
Fluconazole	Fluconazole	36	22
Procto-Med Hc	Hydrocortisone	36	14
Xarelto	Rivaroxaban	36	suppressed
Azelastine Hcl	Azelastine Hcl	35	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	35	32
Mirtazapine	Mirtazapine	35	12
Escitalopram Oxalate	Escitalopram Oxalate	33	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	33	11
Prolia	Denosumab	32	20
Rybelsus	Semaglutide	32	suppressed
Allopurinol	Allopurinol	31	13
Ezetimibe	Ezetimibe	31	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	31	14
Clobetasol Propionate	Clobetasol Propionate	30	12
Oxybutynin Chloride Er	Oxybutynin Chloride	30	11
Terbinafine Hcl	Terbinafine Hcl	30	18
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	29	suppressed
Glimepiride	Glimepiride	29	13
Terconazole	Terconazole	28	17
Buspirone Hcl	Buspirone Hcl	26	suppressed
Entresto	Sacubitril/Valsartan	26	suppressed
Lidocaine	Lidocaine	26	suppressed
Novolog Flexpen	Insulin Aspart	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Metronidazole	Metronidazole	23	13
Trulicity	Dulaglutide	23	suppressed
Furosemide	Furosemide	22	suppressed
Ofloxacin	Ofloxacin	22	12
Ramipril	Ramipril	22	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	22	17
Tacrolimus	Tacrolimus	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	20
Glipizide	Glipizide	21	suppressed
Halobetasol Propionate	Halobetasol Propionate	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Proctozone-Hc	Hydrocortisone	21	12
Telmisartan	Telmisartan	21	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	20	suppressed
Folic Acid	Folic Acid	20	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	20	12
Promethazine Hcl	Promethazine Hcl	20	14
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Dapagliflozin	Dapagliflozin Propanediol	19	suppressed
Fenofibrate	Fenofibrate,micronized	19	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Clotrimazole	Clotrimazole	18	suppressed
Estradiol	Estradiol	18	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Varenicline Tartrate	Varenicline Tartrate	18	suppressed
Admelog Solostar	Insulin Lispro	17	suppressed
Amoxicillin	Amoxicillin	17	17
Donepezil Hcl	Donepezil Hcl	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Levofloxacin	Levofloxacin	17	17
Nitroglycerin	Nitroglycerin	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	11
Loperamide	Loperamide Hcl	15	11
Methylprednisolone	Methylprednisolone	15	14
Nifedipine Er	Nifedipine	15	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Restasis	Cyclosporine	14	suppressed
Alcohol Swab	Alcohol Antiseptic Pads	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Kerendia	Finerenone	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Steglatro	Ertugliflozin Pidolate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
True Comfort Pro Alcohol Pads	Alcohol Antiseptic Pads	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$398.93 · 6 records	Gilead Sciences, Inc.	Cologuard Collection Kit, Livdelzi, QULIPTA, Symbravo	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error